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Long-term effect of respiratory training 
for chronic obstructive pulmonary disease 
patients at an outpatient clinic: a randomised 
controlled trial
Fang Xi1,2, Zheng Wang1, Yong Qi1, Richard Brightwell2, Peter Roberts2, Angus Stewart2, Moira Sim2 
and Wei Wang2,3*
Abstract 
Objective: To assess the effect of respiratory training (RT) on lung function, activity tolerance and acute exacerbation 
frequency with chronic obstructive pulmonary disease (COPD).
Design: A randomised controlled trial.
Setting: Outpatient clinic and home of the COPD patients, Zhengzhou City, China.
Subjects: Sixty participants with COPD were randomised into two groups: an intervention group (n = 30) which 
received the RT in self-management and a control group (n = 30) that received an education program during the 
study.
Intervention: Pulmonary function, activity tolerance and frequency of acute exacerbation of these COPD patients 
were evaluated before and after the program. The intervention and control programs were delivered at monthly out-
patient clinic visits over a period of 12 months. The pulmonary rehabilitation (PR) program was conducted by a physi-
otherapist (who delivered RT to the participant over a minimum of 1 h per visit) for the intervention group, whereas 
the control group received routine health education provided by physiotherapists. The intervention group patients 
were then instructed to perform exercises at home as taught in the RT at least 5 days per week at home.
Results: After 12 months of RT, the lung function and the activity tolerance of the COPD patients in the intervention 
group were significantly improved and the exacerbation frequency was also decreased.
Conclusion: Long-term RT can improve lung function and activity tolerance while decreasing the frequency of acute 
exacerbation for COPD patients.
© 2015 Xi et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made.
Background
Chronic obstructive pulmonary disease (COPD) is a 
lung disease characterised by chronic obstruction of 
lung airflow which interferes with normal breathing 
and is not fully reversible [1]. It is associated with a sig-
nificant reduction in physical activity and psychologi-
cal problems, which contribute to disability and poor 
health-related quality of life (HRQoL) [2]. COPD is a 
common cause of illness and death that affects a large 
and increasing number of individuals in both developed 
and developing countries. Estimates suggest that COPD 
will become the 3rd most common cause of death in the 
world and 5th most common cause of illness in the next 
20 years [3, 4]. Unfortunately, to-date there is no effective 
therapy which can reverse the decline in lung function 
in COPD and the only intervention which can reduce 
the rate of decline is smoking cessation. All existing 
evidence-based clinical practice guidelines recommend 
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the use of pulmonary rehabilitation for the management 
of COPD [5, 6]. PR is an evidence-based, multidiscipli-
nary and comprehensive intervention for symptomatic 
patients who may have decreased functional status [7]. 
Numerous high-quality trials have shown that PR, con-
sisting of exercise training, self-management education, 
nutritional care and psychosocial management, improves 
exercise capacity, symptoms and health-related qual-
ity of life and reduces health-care costs [4, 8, 9]. Despite 
this, many people with COPD do not continue their PR 
program, and long-term maintenance has been difficult 
to achieve after short-term treatment [10]. Although PR 
therapy including supervised exercise training, nutri-
tional support, self-management education, and psycho-
social support is effective for COPD patients, few studies 
have focused on follow up beyond 12  months and long 
term outpatient compliance in a RT program. The effect 
of RT for COPD patients is positive. For example, COPD-
X guildlines [11] and Lin et  al. [12] reported the effec-
tiveness of RT that PR reduces COPD hospitalization. 
Moreover, few PR studies focused on acute exacerbation 
frequency with COPD [13, 14].
This present study aimed to evaluate the impact of a 
12-month RT program on lung function, activity toler-
ance and frequency of acute exacerbations. Pulmonary 
function, activity tolerance and frequency of acute exac-
erbation of these COPD patients were evaluated before 
and after the program during Feb 2010 to April 2012.
Methods
Study design
All participants confirmed their informed consent in 
writing, and this study was approved by the Ethical Com-
mittee of Henan Province People’s Hospital. The study 
was performed in accordance with the ethical standards 
laid down in the 1964 Declaration of Helsinki.
The patients were screened in the Respiratory Depart-
ment of Henan Province People’s Hospital, China. The 
patients were randomised by computer and allocated to 
two groups: intervention and control. Participants visited 
the clinic monthly for the PR and education during this 
12-month program. Pulmonary function, activity tolerance 
and frequency of acute exacerbation of these COPD patients 
were evaluated before and after the program (Fig. 1).
The sample size of this study was estimated by cal-
culation based on the data collected from preliminary 
experiments. The minimum sample size of 23 in each 
group achieves 91 % power to detect a difference of −5.0 
between the null hypothesis that both group means are 
5.0 and the alternative hypothesis that the mean of group 
2 is 10.0 with estimated group standard deviations of 5.0 
and 5.0, and with a significance level (alpha) of 0.05000 
using a two-sided two-sample t test.
Patients
The inclusion criteria:
  • COPD was diagnosed based on the GOLD classifica-
tion [3];
  • COPD clinically stable 8  weeks prior to the study 
(i.e., no symptoms of increased phlegm production 
or phlegm purulence).
The exclusion criteria:
  • hospitalisation;
  • presence of neuromuscular disease;
  • associated respiratory disease;
  • orthopaedic or neurological disease that affected gait;
  • In the last 3 months impairment due to co-morbid-
ities, such as myocardial infarction, heart failure, 
stroke or neoplasm;
  • prior pneumonectomy or other thoracic surgery.
The presence of stable co-morbidities was not consid-
ered an exclusion criterion as most patients with COPD 
are elderly and commonly affected by other multiple co-
morbidities [15].
Lung function measurements
Lung function parameters were collected pre and post 
RT with MIR Spirobank lung function spectrometry 
(Spirobank, Italy). Forced vital capacity (FVC), the forced 
expiratory volume in 1  s (FEV1) and FEV1/FVC were 
evaluated. Exacerbation frequencies were documented 
during the 12-month study. Acute exacerbation was 
defined by exacerbation of cough, dyspnoea or wheez-
ing and increased production of sputum, with or with-
out fever. Two periods of exacerbation in 1  week were 
documented as one exacerbation. The physiotherapist 
followed up the participants’ status by a telephone call 
once a week during the first 2  months and then once 
every 2  weeks subsequently. During the phone call, the 
physiotherapist guided the PR (see more details in the 
following section of “Educational and RT Programs”) 
and informed the relatives about the importance of sur-
veillance. Patients re-visited the hospital every month. 
Patients were individually guided, monitored and the PR 
was increased closely in line with the health status.
Interventions
Educational program
In accordance with the GOLD guidelines, patients in 
both groups were treated with inhaled bronchodilators 
and corticosteroids, and nutrition support therapy as 
required [3]. The control group in their once monthly 
visit to the outpatient clinic received routine health 
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education from a physiotherapist about the development 
and progression of COPD. Compact discs and brochures 
were distributed to the patients and their relatives, in 
the hope that they could learn and continue the PR. The 
patients were required to revisit the outpatient clinic 
monthly where they were interviewed and recorded 
while they also got a general medical review at their clinic 
appointments.
Respiratory training (RT) program
The intervention group received the RT program. The 
RT method was based on studies by Collins et  al. [16], 
Tiep [17] and Mendes de Oliveira et al. [18]. Briefly, the 
method was performed by a combination of pursed-lip 
breathing, abdominal breathing (diaphragmatic breath-
ing) and upper and lower limb exercises. The respiratory 
training included pursed-lip breathing using the follow-
ing methods: inhaling through the nose while silently 
counting from one to two, and then pursing the lips to 
slowly exhale while silently counting from 1–4, 5 min at a 
time, three times per day.
The abdominal breathing (diaphragmatic breathing) 
exercise included inflating the abdomen while inhaling 
and deflating the belly while exhaling. While practising, 
the participants placed one hand on the chest and the 
other on the abdomen. Then they relaxed and bloated the 
abdomen when inspiring; tightened up and contracted 
the abdomen when expiring. This was performed for 
10 min each time and twice per day in the morning and 
evening, and was increased in terms of the lasting time 
of the exercise until it became the normal method for 
breathing throughout the day.
The upper limb exercises were performed with hand 
weights while seated comfortably and consisted of ten 
repetitions of elbow flexion, ten repetitions of elbow 
abduction, ten repetitions of shoulder abduction and ten 
repetitions of shoulder flexion. Upper limb training was 
performed daily beginning with a duration of 5 min each 
time, gradually increasing to 20 min. The lower limb exer-
cises were performed with ankle weights while patients 
were seated comfortably and consisted of ten repetitions 
of hip flexion and ten repetitions of knee extension, ini-
tially for 10 min per day and gradually increasing up to 
20 min each day.
A minimum of 1  h of the exercise was performed on 
their monthly visit at the outpatient clinic and participants 
were advised to continue their exercises at home for a min-
imum of 5 days per week. The participants were required 
to attend the outpatient clinic monthly where they under-
went clinical assessment and interviews as outlined below.
Physical measurements
At monthly outpatient clinic visits, clinical measure-
ments, tests and surveys were performed blind by asses-
sors. Participants’ height and weight were measured. 
The modified Medical Research Council (MMRC) dysp-
noea scale [3], COPD assessment test (CAT) and the 
Saint George’s respiratory questionnaire (SGRQ) were 
applied [19]. The 6-Minute Walk Test (6MWT) was 
conducted in a 50 metre long corridor. During 6MWT 
the patients were instructed to walk as fast as possible 
for 6  min and to then decrease speed or interrupt the 
test if experiencing severe dyspnoea or any other dis-
comfort. Heart rate, dyspnoea, and oxygen saturation 
were measured before and after each test. The partici-
pant was guided and encouraged to complete the test. 
The body mass, airflow obstruction, dyspnoea and exer-
cise capacity index (BODE index) for COPD was calcu-
lated accordingly [20]. A COPD assessment test (CAT) 
was performed by an experienced observer. The statisti-
cian who performed the data analysis blind from all the 
clinical tests.
Statistical analysis
SPSS 15.0 software (SPSS Inc, Chicago, IL) was used for 
statistical analysis. Data were reported as mean  ±  SD 
for continuous variables and frequencies for categorical 
variables. P values of <0.05 were considered statistically 
significant.
Results
Baseline characteristics
Seventy-five COPD patients were eligible for enrolment, 
out of which 70 consented and were randomised into the 
RT and control groups respectively. After group assign-
ment, ten patients (five from each group) were hospital-
ised because of respiratory infections during the study 
and had to be excluded. Following informed consent, 60 
COPD patients were randomised and divided into two 
groups, an intervention group (n  =  30) which received 
the RT and a control group (n = 30) which received an 
education program during the study. In the end, the study 
was completed with groups of participant size 30 each.
As shown in Table  1, the mean FEV1 was 41.9  % 
(±2.6  %) in the intervention group versus 43.33  % 
(±3.6 %) in the control group; the mean FVC was 68.7 % 
(±15.5 %) in the intervention group versus 65.3 % (±14.8) 
in the control group. The age, sex, education background, 
disease course and lung function parameters were not 
significantly statistically different between the interven-
tion and control groups (P > 0.05).
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The effect of PR on symptoms
Table  2 reflects the changes in CAT score, SGRQ score, 
6MWT distance, BODE index and MMRC score. A 
decrease of two points (from six to four) in the score for the 
BODE index for the patients in the intervention group was 
noted. This change was due to the decrease in dyspnoea 
in the intervention group, whereas we did not find such 
a BODE index decrease in the control group. The BODE 
index and the 6MWT distance were significantly different 
between the intervention group and the control group after 
pulmonary rehabilitation (P < 0.05 in each situation).
The effect of PR on lung function
The lung function parameters before and after inter-
ventions are shown in Table 3. There was no significant 
change in any of the pulmonary function parameters pre 
and post in the control group. However, RT improved 
FEV1, FVC and FEV1/FVC in the intervention group 
(P  <  0.05 in each situation). FEV1 was significantly dif-
ferent between the intervention group and the control 
group after pulmonary rehabilitation (P < 0.05).
The effect of PR on acute exacerbation frequencies
The acute exacerbation frequencies were 1.30 (SD ± 1.02) 
in the intervention group compared with 2.40 (±1.30) 
Diagnosis of COPD
Participants (n=70)
Declined (n=5)
Intervention group
(n=35)
Control group
(n=35)
Discontinued intervention
due to hospitalisation
(n=5)
Lost to follow up
(n=5)
Completed the study 
(n=30)
Completed the study    
(n=30)
Fig. 1 Flowchart of participants
Table 1 Demographic characteristics of the patient population
FVC forced vital capacity, FEV1 forced expiratory volume in one-second
Characteristics Control group (n = 30) Intervention group (n = 30) χ2 test* t test P value
Age, year 73.0 ± 5.8 75.4 ± 6.6 0.60* 0.439
Female 7 8 0.09 0.764
Ex-smokers 22 24 0.37 0.543
Smoking index (pack year) 26.2 ± 4.6 25.3 ± 4.8 0.44* 0.562
Hypertension 14 12 0.27 0.603
Coronary artery disease 7 6 0.10 0.751
Stroke 4 4 0.14 0.708
Type 2 diabetes 3 4 0.001 0.974
Numbers of concomitant diseases 2.3 ± 0.7 2.2 ± 1.0 0.53* 0.467
Resting blood gas findings (FiO2 21 %)
 PaO2 <60 mmHg 3 2 0.001 0.467
 PaCO2 >45 mmHg 4 6 0.48 0.488
 PH <7.35 2 1 0.001 0.974
FVC (% of predicted) 65.3 ± 14.8 68.7 ± 15.5 1.05* 0.306
FEV1 (% of predicted) 43.33 ± 3.6 41.9 ± 2.6 0.616* 0.533
 50–80 3 5 0.14 0.708
 30–50 11 10 0.07 0.791
 ~30 16 15 0.07 0.791
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times in the control group, which was statistically sig-
nificantly different between both groups (t  =  −3.639, 
P < 0.01).
Discussion
PR is an evidence-based, multidisciplinary program whose 
main components are supervised exercise training, nutri-
tional support, self-management education, and psycho-
social support. It could increase the patients’ endurance 
limit due to hypoxia, relieve the symptoms, improve their 
exercise capabilities and quality of life, and has become a 
major part of therapy in stabilising COPD. However, the 
availability of PR programs in most countries is limited and 
few patients are enrolled into such a treatment modality 
[21–23]. Moreover, PR carried out in a clinical setting and 
based on hospital guidelines requires qualified health care 
professionals, equipment and facilities, which are expensive 
to maintain and this cost contributes toward the reduc-
tion in the availability of PR at health care providers [24]. 
COPD patients are oftern reduce their activities due to pro-
gressive, irreversible airway obstruction which lowers their 
exercise capacity and quality of life. Some even require 
home care due to significant dyspnoea. Exercise training 
is the core of lung function rehabilitation [25], which can 
improve patients’ exercise endurance, alleviate their dysp-
noea, improve their ventilation burden and finally, facilitate 
the rehabilitation of the whole body.
This study randomly assigned COPD patients to inter-
vention and control groups to evaluate the effects of RT. 
The results showed that RT significantly improves the 
parameters of pulmonary function, including FVC, FEV1 
and FEV1/FVC (%). The results for FVC are similar to 
the study by Ngaage et al. [26], who showed that patients 
with COPD have similar outcomes after physical train-
ing for the upper and lower extremities and diet educa-
tion. Pursed-lip respiration could increase the inspiration 
maneuver, slow down the expiration air flow, and reduce 
the residual lung volume. Breath-holding for two or 3  s 
could improve the distribution of air in the alveoli and 
alleviate patients’ dyspnoea.
Abdominal breathing elevates the diaphragm and, thus, 
improves lung function, and the results of this study are 
similar to those reported by Lin et  al. [27], who evalu-
ated the effects of respiratory training in 40 patients 
with COPD, and Chao et al. [28] who evaluated modified 
abdominal breathing in 25 patients with COPD. These 
data suggested that RT could improve the strength and 
endurance of respiratory muscles, and improve lung 
functions.
The 6MWT is a widely accepted method for determin-
ing functional capacity for exercise, being commonly 
used in field studies due to its low-cost, reproducibility, 
objectivity and easy application in relation to patient age 
and education level [5, 29]. The intervention of RT in this 
Table 2 The effect of PR on symptoms
* P < 0.05 compared with that before rehabilitation. Data are presented as mean ± SD
# P < 0.05 compared with that of the control group before rehabilitation
& P < 0.05 compared with that of the control group after rehabilitation
Control group (n = 30) Intervention group (n = 30)
Before rehabilitation After rehabilitation Before rehabilitation After rehabilitation
CAT score 14 ± 2.4 8 ± 2* 14.6 ± 2.5 7.2 ± 1.8*
SGRQ score 42.33 ± 4.6 63.66 ± 3.6* 38.2 ± 3.6# 59.6 ± 5.4*
6MWT distance (m) 273 ± 19 281 ± 22 284 ± 18 330 ± 19*,&
BODE index 6 ± 0.44 4 ± 0.38* 6 ± 0.7 6 ± 0.5&
MMRC score 2 ± 0.6 1 ± 0.8* 2 ± 0.7 1 ± 0.5*
Table 3 The effect of the rehabilitation program on lung function
* P < 0.05 compared with that before rehabilitation. Data are presented as mean ± SD
& P < 0.05 compared with that of the control group after rehabilitation
Control group (n = 30) Intervention group (n = 30)
Before rehabilitation After rehabilitation Before rehabilitation After rehabilitation
FEV1(L) 1.45 ± 0.17 1.43 ± 0.19 1.41 ± 0.16 1.52 ± 0.16*,&
FVC(L) 2.42 ± 0.19 2.45 ± 0.20 2.42 ± 0.20 2.46 ± 0.19*
FEV1/FVC (%) 60.53 ± 6.68 59.53 ± 6.89 58.03 ± 6.99 60.43 ± 6.88*
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study improved the 6-min walking distance. These results 
are consistent with the results reported from Spencer 
et al. [30] and Magadle et al. [31].
The frequency of exacerbations is an important out-
come indicator for COPD. Acute exacerbation of COPD 
(AECOPD) can signify ineffective treatment and frequent 
episodes of AECOPD are associated with increased fre-
quency and duration of hospitalisation, poorer qual-
ity of life, and poorer prognosis. This study showed that 
RT could improve lung function, delay the degeneration 
of lung function, and improve the efficacy of respira-
tion, thus potentially reducing the frequency of  disease 
exacerbation and treatment cost, as well as improving 
prognosis.
Limitations
Our intended sample size was at least 60, with 30 in each 
group, based on the power calculations and pragmatic 
decisions on what was achievable. With the loss to follow 
up we still achieved the required minimum of 23 partici-
pants in each group. We acknowledge this small sample 
size could influence the analysis with limited statistical 
power (91  %) to detect the difference. In addition, we 
omitted the use of SaO2/SpO2 values before and after 
6MWT,  which would have provided useful information 
about the functional status of the participants.
Recommendations
Healthcare workers should be well trained in manage-
ment of COPD, with the ability to assess, diagnose, treat 
or refer, and educate patients and their caregivers and 
this is particularly vital for a country like China which is 
marching rapidly into an ageing society [32, 33]. A key 
policy priority should therefore be to plan for the long-
term care of people with COPD and the delivery of PR 
in community-based care. Additionally, more research 
should be done to improve understanding of the different 
social and environmental risk factors and the ecology of 
healthcare for chronic disease control and management 
[34].
Conclusion
The results of this study showed that long term 
(12  months) RT can improve lung function and activity 
tolerance, and decrease frequency of acute exacerbation 
for COPD patients. RT as a simple to learn, cost-effective 
method is worthy of promotion.
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